Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
PATROL
A Multi-center, Prospective, Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus
PATROL
A Multi-center, Prospective, Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus
Sponsor study identifier
observational
4,045
1 country
7
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
October 2009
Actual (reported)This study will address the proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline, among outpatients coming to the Korean primary care nationwide.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2009
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 28, 2009
Actual (reported)May 2009
Date type not reportedThis date has not been verified as actual or estimated.
May 1, 2009
Actual (reported)October 2009
Actual (reported)Proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline
At baseline and Endpiont (after 2months)
The treatment goal of risk factors is based on ADA guideline.
At baseline and Endpiont (after 2months)
Type II DM and Hypertension and/or Hyperlipidemia
Type II DM and Hypertension and/or Hyperlipidemia
Research Site
Busan, South Korea
Research Site
Cheiju, South Korea
Research SIte
Daegu, South Korea
Research Site
Gwangju, South Korea
Research Site
Hongseong, South Korea
Research Site
Seoul, South Korea
Research Site
Sungman, South Korea
Joonwoo Bahn
ASTRAZENECA, Korea Medical Department
4,045 participants (actual enrollment reported by the registry).
First Submitted
April 28, 2009
First Posted
May 1, 2009
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Contact the study team to confirm eligibility.
Study Completion
October 2009
Actual (reported)Last Updated
November 3, 2009
Record last verified: 2009-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: